Firefly Neuroscience (AIFF) plans to sell 30,126 NASDAQ shares
Rhea-AI Filing Summary
Firefly Neuroscience (AIFF) filed a Form 144 notifying the proposed sale of 30,126 shares of common stock, scheduled to be sold on 10/09/2025 on NASDAQ. The filing lists an aggregate market value of $86,694.86 for the shares and shows 13,448,848 shares outstanding, making the block roughly 0.224% of the outstanding stock. The securities were acquired on 08/12/2024 as merger consideration, with 1,636,990 shares received in that transaction. No securities were reported sold by the same person in the past three months. The filer certifies they are not aware of undisclosed material adverse information.
Positive
- Transparent disclosure of a proposed insider sale via Form 144, including broker and timing
- Securities were acquired as merger consideration on 08/12/2024, providing a clear provenance for the shares
- No sales in the past three months reported for the selling person, indicating no recent offloads
Negative
- Proposed sale increases available float by about 0.224%, which could exert minor downward pressure on the share price if executed
- Sale timing is concentrated with an approximate sale date of 10/09/2025, which could cluster supply
Insights
Small insider sale disclosed; negligible pressure on float but worth noting timing.
The notice reports a proposed sale of 30,126 shares valued at $86,694.86 to occur on 10/09/2025, executed through Haywood Securities on NASDAQ. The shares were acquired as merger consideration on 08/12/2024, with 1,636,990 shares received in that earlier transaction.
This block represents about 0.224% of the 13,448,848 shares outstanding, so the immediate market impact should be limited. Monitor actual trade execution on or after 10/09/2025 for any short-term price effects and any subsequent 144 filings that would signal larger follow-on dispositions.